Journal of Functional Biomaterials最新文献

Acellular dermal matrices (ADMs) are widely used in soft-tissue reconstruction, yet the optimal timing for split-thickness skin grafting (STSG) remains unsettled. We conducted a single-center retrospective cohort study (January 2023-August 2025) of adults undergoing ADM-based reconstruction with Integra^® Double Layer (IDL), Integra^® Single Layer (ISL), or Nevelia^®. Primary endpoints included length of stay (LOS), STSG requirement and timing, and in-hospital complications; secondary endpoints included spontaneous epithelialization. Prespecified adjusted analyses (linear/logistic models) controlled for age, sex, etiology, anatomical site, diabetes/PAOD, smoking, wound size (when available), wound contamination, and matrix type. Histology and immunohistochemistry (H&E, Masson trichrome, CD105, D2-40) assessed matrix integration and vascular/lymphatic maturation. Seventy-five patients were included (IDL n = 40; ISL n = 20; Nevelia n = 15). On multivariable analysis, matrix type was not an independent predictor of LOS (ISL vs. IDL β = +2.84 days, 95% CI -17.34 to +23.02; Nevelia vs. IDL β = -4.49 days, 95% CI -16.24 to +7.26). Complications were infrequent (6/75, 8.0%) and comparable across matrices; spontaneous epithelialization occurred in 3/75 patients (4.0%). A day-14 grafting strategy, applied only after documented clinical integration, was feasible in 30/75 (40.0%) patients without excess complications. Histology/IHC at 3-4 weeks demonstrated CD105-positive, perfused capillary networks with abundant collagen; at 4-6 weeks, D2-40-positive lymphatic structures confirmed progressive neo-dermis maturation, supporting the biological plausibility of earlier grafting once integration criteria are met. In this cohort, outcomes were broadly similar across matrices after adjustment. A criteria-based early STSG approach (~day 14) appears safe and operationally advantageous when integration is confirmed, while a minority of defects may heal without grafting. Prospective multicenter studies with standardized scar/functional measures and cost analyses are needed to refine patient selection and graft timing strategies.

Collagen-based biomaterials are widely used, but their relatively rapid biodegradation can limit functional duration. Such collagen constructs are widely used as barrier membranes in guided tissue and bone regeneration, where controlled degradation is essential for maintaining function. Although conventional crosslinking methods extend stability, they may introduce cytotoxicity, alter mechanical behavior, or hinder tissue integration. This study evaluated whether incorporating L-serine, a polar amino acid capable of hydrogen bonding, could modulate collagen structure and slow degradation without chemical crosslinking. L-Serine was selected because its hydroxyl-containing side chain can engage in biocompatible, hydrogen-bond-mediated interactions that offer a mild, non-crosslinking means of stabilizing collagen. Collagen scaffolds, prepared by incorporating L-serine into a collagen hydrogel followed by drying, were produced with 0-40 wt% L-serine and characterized using X-ray diffraction, Fourier-transform infrared spectroscopy, circular dichroism, and scanning electron microscopy. In vivo degradation was assessed in a subcutaneous mouse model comparing unmodified collagen, collagen containing 40 wt% L-serine, and a commercially available bilayer porcine collagen membrane (Bio-Gide^®, composed of type I and III collagen), with residual area quantified by serial sonography and histological evaluation. Low-to-moderate L-serine incorporation preserved triple-helical features, while 40 wt% led to crystalline domain formation and β-sheet enrichment. L-serine-treated collagen exhibited significantly greater residual area (2.70 ± 1.45 mm²) than unmodified collagen (0.37 ± 0.22 mm², p < 0.05), although Bio-Gide^® remained the most persistent (5.64 ± 2.76 mm²). These findings demonstrate that L-serine incorporation can modulate collagen structure and degradation kinetics through a simple, aqueous, and non-crosslinking approach. The results provide preliminary feasibility data supporting amino acid-assisted tuning of collagen resorption properties and justify further evaluation using membrane-specific fabrication and application-relevant testing.

In the original publication [...].

Carbon dots have emerged as promising nanocarriers for drug delivery due to their unique physicochemical properties and biocompatibilities. Here, the potential of leaf-derived carbon dots (named as SBL_CD), derived from Seabuckthorn (Hippophae rhamnoides L.), was illustrated as a novel nano-formulation for bioactive compound delivery. Seabuckthorn leaves, rich in flavonoids, are the waste product during the production of Seabuckthorn fruits. The wasted leaves were utilized to synthesize carbon dots via a hydrothermal method. The resulting SBL_CD, characterized by TEM, FT-IR and Raman spectroscopy, exhibited a diameter of ~5 nm in both amorphous and quasi-crystalline forms. Applications of SBL_CD in cultures demonstrated robust properties of anti-inflammation and inducing neuronal cell differentiation. Furthermore, SBL_CD was able to encapsulate luteolin, a bioactive flavonoid. The enhanced delivery efficiency translated to superior biological activity, with SBL_CD-luteolin requiring only 1.50 μg/mL in achieving the EC₅₀ efficacy, as compared to 6.82 μg/mL for free luteolin in pNF200-Luc expression assays. This approach not only valorizes Seabuckthorn leaf by-products but also potentially improves the efficacy of encapsulated flavonoids. The development of SBL_CD as a multifunctional platform for flavonoid delivery represents a promising strategy in enhancing the efficacy of neuroactive compounds, combining anti-inflammatory effects (>70% cytokine suppression) with enhanced cellular uptake (4.5-fold increase).

Calcium phosphate cements (CPCs) and biomaterials, such as mesoporous bioactive glass (MBG), are critical for bone tissue engineering. This study aimed to 3D-print CPC scaffolds modified with MBG to enhance their osteogenic potential and regenerative ability. MBG powder was synthesized and characterized using transmission electron microscopy (TEM), X-ray diffraction (XRD), and nitrogen adsorption-desorption techniques. A commercial CPC ink (hydroxyapatite/α-tricalcium phosphate) was mixed with 5% MBG (w/w; CPC/MBG), and, after rheological assessment, the mixture was used to obtain scaffolds via 3D printing. These scaffolds were then tested for chemical, morphological, and mechanical properties, as well as ion release analysis. Unmodified CPC 3D-printed scaffolds served as controls. Biological experiments, including cell viability, DNA content, cell adhesion/spreading, and osteogenic gene expression, were performed by seeding alveolar bone-derived mesenchymal stem cells onto the scaffolds. Statistics were performed using Student's t-test and ANOVA with post hoc tests (α = 5%). MBG characterization showed a typical mesoporous structure with aligned microchannels and an amorphous structure. Both formulations released calcium and phosphate ions; however, CPC/MBG also released silicon. Cell viability, adhesion/spreading, and DNA content were significantly greater in CPC/MBG scaffolds compared to CPC (p < 0.05) after 3 and 7 days of culture. Furthermore, CPC/MBG supported increased expression of key osteogenic genes, including collagen (COL1A1), osteocalcin (OCN), and Runt-related transcription factor 2 (RUNX2), after 14 days (p < 0.05). The combination of CPC ink with MBG particles effectively enhances the biocompatibility and osteogenic potential of the scaffold, making it an innovative bioceramic ink formulation for 3D printing personalized scaffolds for bone regeneration.

Denture base resins are susceptible to microbial colonization, and current antibacterial additives often lose effectiveness and may weaken material properties. This study evaluated whether immersion in a quaternary ammonium methacryloxy silane (QAMS)-containing monomer can enhance antibacterial activity without compromising the mechanical properties of digital light processing-printed urethane dimethacrylate denture base resin. Specimens of printed denture base resin were immersed in mixtures of denture base resin and a QAMS-containing monomer at ratios of 10:0 (Control), 7:3 (K3), 5:5 (K5), 3:7 (K7), and 0:10 (K10), followed by post-curing. Flexural strength and modulus were measured by three-point bending, and surface hardness was assessed by Vickers microhardness testing. Antibacterial activity against Streptococcus mutans was assessed by inhibition-zone and colony-counting assays. All QAMS-treated groups preserved flexural strength, with a slight reduction in modulus in K5 (p < 0.05), while hardness remained unchanged. Antibacterial activity improved in all QAMS-treated groups; K5 and K7 showed the strongest results. Surface analyses using scanning electron microscopy and energy-dispersive X-ray spectroscopy verified formation of a Si-rich modified layer. QAMS immersion followed by post-curing produced a stable, contact-active antibacterial surface without reducing mechanical properties. Among the formulations, K7 (~21 wt% QAMS) provided the most favorable balance of antibacterial activity and mechanical performance.

Magnetosomes (MTS), membrane-enclosed magnetic nanoparticles naturally biomineralized by magnetotactic bacteria, are promising materials for tumor hyperthermia owing to their good biocompatibility and heating efficiency. However, their application is limited by poor suspension stability and low injectability at high concentrations. This study aimed to enhance magnetosome stability and delivery performance through surface cationization combined with collagen matrix stabilization. The resulting cationic magnetosomes (CMTS) exhibited an increased positive charge on the outer membrane. Collagen, functioning as a negatively charged matrix under mildly alkaline conditions, effectively stabilized the cationic magnetosomes, forming CMTS-collagen aqueous suspensions (CMTS-Colas) that remained well-suspended for over 24 h and could be easily resuspended after 10 days of storage. Compared with native magnetosome suspensions, CMTS in collagen displayed smaller hydrodynamic diameters and significantly improved injectability through 26G and 31G fine needles. Under an alternating magnetic field, 2 mg/mL CMTS-Colas efficiently induced over 98% apoptosis in hepatoma cells after two treatment sessions and led to complete loss of cell viability after three sessions. These findings demonstrate that CMTS-Colas substantially improve the suspension stability and injectability of magnetosomes while maintaining strong hyperthermic efficacy, suggesting a promising strategy for stabilizing magnetosomes and potentially benefiting other charged, aggregation-prone magnetic biomaterials.

Bone cements based on polymethyl methacrylate (PMMA) remain the clinical standard for joint replacement and vertebral augmentation but suffer from several major challenges. These include excessive stiffness compared with cancellous bone, lack of resorption and osteoconductivity, and thermal necrosis during curing. Calcium phosphate cements (CPCs) are bioactive and resorbable but tend to exhibit low mechanical strength, poor injectability and brittle fracture. The work reported herein developed an injectable composite bone cement by combining spherical, porous, sintered β-tricalcium phosphate (β-TCP) particles with a cyanoacrylate adhesive. The β-TCP granules provided bioactivity and a favorable microarchitecture while the cyanoacrylate ensured strong adhesion and rapid setting. Ion substitution with Mg, Na and Si was found to modify the surface acidity of the material while also inhibiting cyanoacrylate polymerization, thereby extending the setting time and lowering the exotherm temperature. This composite exhibited high chemical stability, smooth injectability and early surface reactivity indicative of osteoconductivity. The compressive strength of the material stabilized at approximately 40 MPa and so exceeded that of cancellous bone. This new material also showed ductility, energy absorption and superior impact resistance, although its tensile and fatigue resistance remained limited. Importantly, the composite provided strength comparable to that of PMMA in cemented models during fixation tests and significantly outperformed CPCs in cementless tibial tray fixation experiments. These findings demonstrate that the present β-TCP/cyanoacrylate cement bridges the gap between PMMA and CPCs by combining injectability and mechanical reliability with bioactivity. This cement is therefore a promising next-generation option for minimally invasive osteoporotic fracture treatment and revision arthroplasty.

The development of advanced biomaterials for corneal applications requires robust translational platforms that faithfully replicate human characteristics. Porcine corneas are increasingly recognized for ophthalmic research. Their unique combination of anatomical similarity, biomechanical comparability, and accessibility make them highly suitable for preclinical evaluation of innovative therapies, bridging the gap between preclinical discovery and clinical application. This review outlines the utility of porcine corneal models in validating advanced biomaterials, particularly in ex vivo settings, focusing on current methodologies, while addressing challenges and future directions. We aim to underscore the potential of porcine corneal models to accelerate the translation of next-generation biomaterials into clinically relevant corneal therapies.

The primary reason of dental restoration failure is the recurrence of caries, driving research to incorporate quaternary ammonium salts (QASs) into resin-based composites (RBCs). Given the prolonged contact of these materials with oral tissue, this in vitro study assessed the biocompatibility (cytotoxicity and genotoxicity) profiles of experimental RBCs modified with cetyltrimethylammonium bromide (CTAB) and dimethyldioctadecylammonium bromide (DODAB), using two restorative materials: an unmodified-experimental composite, KE, and Flow-Art (FA) as comparative standards. The primarily novelty of this study is the direct comparison of the cellular safety profiles of CTAB vs. DODAB when incorporated into RBCs. Human fibroblast BJ cells were exposed to composite eluates for 24 h, and cell viability (MTT assay), the percentage of apoptotic and necrotic cells (the Annexin V/Propidium Iodide (PI) flow cytometry method), and DNA damage (the alkaline comet assay) were quantified. Among the compounds evaluated, only CTAB caused a significant, dose-dependent decrease in BJ cell viability, primarily by inducing late apoptosis or necrosis. Cell viability was severely reduced, dropping by 84% at 2 wt% CTAB (p < 0.001) compared to control. Consistent with this effect, CTAB also induced a dose-dependent increase in DNA damage. In contrast, the DODAB-modified composites, along with the KE and FA controls, exhibited non-cytotoxic and non-genotoxic profiles across all tested concentrations. This innovative comparative assessment highlights that DODAB exhibits superior cellular safety, offering vital guidance to prioritize its use for developing safe and effective next-generation antibacterial dental composites. Conversely, CTAB is precluded for clinical use at these concentrations due to its observed toxicity.